Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Blueblood Ventures Ltd has ....
Awaiting price reaction for this filing.
Blueblood Ventures Limited has notified BSE that its Board of Directors meeting is scheduled for May 27, 2026 at Greater Kailash-II, New Delhi. The primary agenda is to consider and approve the Audited Standalone Financial Results for the half-year and financial year ended March 31, 2026. Additionally, the company confirmed that the trading window for insiders was closed from March 31, 2026 and will reopen on May 30, 2026. This is a standard regulatory intimation for upcoming quarterly/annual results disclosure.
This is a routine filing indicating the company will release its annual financial results shortly. No specific financial data or material disclosures are provided in this notice. Investors should watch for the actual results announcement expected around May 27-28, 2026, when trading window reopens.